MZT(株)ゼブラフィッシュ創薬研究所

  • HOME
  • 研究開発
  • メンバー
  • アルバム
  • リンク
  • 研究員募集
  • アクセス
  • HOME
  • >
  • 研究員募集
  • >
  • 詳細

最近の記事

2025/05/02
新規蛍光色素ZMB741によるポドサイトパチー治療薬スクリーニング
2025/04/23
Screening of a New Fluorescent Dye, ZMB741, for the Treatment of Podocytopathy
2025/02/21
新しいoncocardionephrologyの展開
2025/01/01
DXAIゼブラフィッシュ創薬セミナーのご案内
2024/10/01
大学院生募集中 2024年10月16日(水)ー18日(金)
2024/07/01
患者がん移植ゼブラフィシュモデルの個別化医療戦略
2024/06/20
Creation and application of a new high-throughput individual zebrafish nephrotoxicity screening system
2024/06/06
AI(人工知能)ゼブラフィッシュ創薬の新しい展開
2024/05/29
システムズ薬理学大学院入試説明会
2024/05/10
令和6年度10月入学・令和7年度4月入学募集 三重大学大学院医学系研究科 医科学専攻修士課程・生命医科学専攻博士課程 入学試験説明会

一覧に戻る

2019/03/01
  • CiteULike
  • reddit
  • StumbleUpon
  • linkedin
  • Delicious
  • Mendeley
  • はてなブックマーク
  • Youtube
  • Google+
  • Twitter
  • Facebook

Graduate Student in Systems Pharmacology

Systems Pharmacology
https://zqsp-mie-u.org

The Systems Pharmacology of Mie University has particular strengths in the areas of zebrafish-based drug discovery and precision medicine.
Systems pharmacology is defined to identify the gene clusters which are involved in determining the responsiveness and to distinguish responders and non-responders to a given drug. Genome sequencing, transcriptome, proteome, metabolome and phenome analysis are of particular significance in systems pharmacology. Sequencing is used to locate polymorphisms, and monitoring of functional gene expression can provide clue about the genomic response to disease and treatment. The transcriptome analysis can be done by methods of differential hybridization (cDNA microarray, oligomicrochip et al.) and RNA seq. We used transcriptome/proteome/metabolome/phenome analysis to identify therapeutic target genes by studying change of gene expression in animal models(zebrafish) and patient-derived xenograft zebrafish model of various diseases and found novel drug target candidates through this systems pharmacological strategy. The systems pharmacology has the potential for strategy to define novel drug targets in various diseases and holds the promise that drugs might be precision medicine for each individual patient.

J. Pharmacol Tox Met. 96:34, 2019, IJMS in press, 2019, Heliyon 3(3): e00266, 2017, J. Clin.Invest.104:59-66,1999, Frontiers in Pharmacol. 7:162, 2016, Frontiers in Pharmacol. 7:206, 2016, Frontiers in Pharmacol. 7:142, 2016, J. Cardiovasc. Pharm.36,S1-S4,2000, J.Biol.Chem. 276,19921-19928, 2001, Pharmacogenomics J.3,183-188,2003, Circulation;110(13):1839-1846 2004, Nutr Metab (Lond). 20;12:17, 2015, Biomaterials.2015, 52:14-25, Toxicol Sci. 143(2):374-84, 2015, FEBS Letters 588:3409, 2014, PLoS One. 15;9(1):e85439, 2014, ACS Chem. Neurosci., 4 (8), 1183-8211;11932013, Molecular Biotechnology 55:131-142, 2013, PLoS ONE 7(12): e52549, BMC Neuroscience 11:116,2010, BMC Physiology10:21, 2010,

関連リンク

  • Department of Systems Pharmacology Mie University Graduate School of Medicine
  • Mie University Medical Zebrafish Research Center

関連ファイル

  • Systems Pharmacology of MIe University